New Expert Consensus Aims to Standardize Surgery for Childhood Kidney Cancer

A new expert consensus published in World Journal of Pediatric Surgery provides 34 recommendations to standardize surgical management of unilateral Wilms tumor, aiming to reduce complications and improve outcomes for children with the most common pediatric kidney cancer.

Bay Area Metrowire Staff
••Healthcare
New Expert Consensus Aims to Standardize Surgery for Childhood Kidney Cancer

A new expert consensus has been published to standardize the surgical management of unilateral Wilms tumor (WT), the most common primary malignant kidney tumor in children. Developed by the Oncology Surgery Group and Urology Surgery Group of the Pediatric Surgery Branch of the Chinese Medical Association, the consensus appeared in the World Journal of Pediatric Surgery on 17 June 2026 (DOI: 10.1136/wjps-2026-001204). The guidance addresses wide variations in surgical practice that can lead to tumor rupture, incomplete staging, recurrence, and unnecessary organ removal.

The consensus offers 34 recommendations based on 17 clinical questions, covering surgical timing, biopsy, incision, renal vessel control, lymph node sampling, tumor thrombus, rupture, recurrence, metastases, nephron-sparing surgery (NSS), minimally invasive surgery (MIS), horseshoe kidney, special populations, and follow-up. It emphasizes complete tumor resection, accurate lymph node sampling, and multidisciplinary care while preserving renal function and improving long-term outcomes. The recommendations target pediatric surgeons, oncologists, urologists, and multidisciplinary teams.

Key recommendations include immediate radical nephrectomy for resectable tumors and preoperative chemotherapy for selected high-risk or initially unresectable cases. Immediate surgery is discouraged for patients with confirmed germline WT1 mutation, solitary kidney, severe anesthetic risk, or tumor thrombus above the hepatic veins. Percutaneous biopsy is generally not recommended but is suggested when renal origin is unclear, benign or non-WT disease is suspected, or in stage IV patients and those older than 10 years. A transverse abdominal or thoracoabdominal incision is preferred, and renal pedicle vessels should be ligated early when possible.

Adequate lymph node sampling—ideally 6 to 10 nodes from renal hilar, aortocaval, paraaortic, aortic bifurcation, celiac trunk, superior mesenteric artery, and iliac sites—improves staging and keeps the false-negative rate below 10%. The ureter should be divided distal to the iliac bifurcation, and the adrenal gland and adjacent organs should be preserved unless directly invaded. Tumor thrombus management follows the Daum classification, with neoadjuvant chemotherapy for thrombi above the hepatic veins and multidisciplinary care for atrial extension. For recurrence, second-line chemotherapy is preferred, while late isolated pulmonary or central nervous system lesions may be resected. NSS is not routine and requires strict criteria; MIS may be considered in selected cases at experienced centers, with conversion to open surgery when necessary.

The consensus is intended as a practical framework rather than a rigid protocol. The authors stress that complete resection and accurate staging remain non-negotiable, but surgeons must balance oncologic control with renal preservation and avoid unnecessary harm. They emphasize that multidisciplinary discussion is essential for complex thrombus, recurrent disease, and unusual presentations, and that conversion from MIS to open surgery should be viewed as sound judgment rather than failure. The goal is safer surgery, better staging, and fewer avoidable recurrences.

This consensus can help align care around common standards, supporting preoperative risk assessment, appropriate chemotherapy, adequate lymph node sampling, organ-preserving approaches when safe, and structured follow-up. In resource-limited settings, the framework may guide referral and multidisciplinary planning. The authors call for future studies to refine patient selection for NSS and MIS, improve rupture prediction, standardize lymph node mapping, and clarify anticoagulation and radiotherapy decisions. Ultimately, the consensus aims to support more consistent, individualized care for children with unilateral WT, addressing a critical need given that surgical management remains inconsistent, especially for large tumors, adjacent-organ invasion, intravascular extension, and lymph node biopsy. The full consensus is available at (DOI: 10.1136/wjps-2026-001204).

Blockchain Registration

QR Code for Blockchain Registration